UBS Group
HLF icon

UBS Group’s Herbalife HLF Stock Holding History

UBS Group’s Portfolio HLF Stock Details HLF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-117,400
Closed -$4.8M – 10511
2021
Q4 		$4.8M Buy
+117,400
New +$4.89M ﹤0.01% 2864
2020
Q1 		– Sell
-198,700
Closed -$9.47M – 8135
2019
Q4 		$9.47M Buy
+198,700
New +$8.61M ﹤0.01% 2007
2019
Q1 		– Sell
-1,737,700
Closed -$102M – 7891
2018
Q4 		$102M Hold
1,737,700
– – 0.05% 361
2018
Q3 		$94.8M Sell
1,737,700
-374,500
-18% -$20.7M 0.04% 423
2018
Q2 		$113M Sell
2,112,200
-400
-0% -$21K 0.05% 365
2018
Q1 		$103M Sell
2,112,600
-23,118,200
-92% -$981M 0.04% 379
2017
Q4 		$854M Buy
25,230,800
+16,407,400
+186% +$575M 0.35% 54
2017
Q3 		$299M Buy
8,823,400
+661,400
+8% +$22.6M 0.14% 166
2017
Q2 		$291M Sell
8,162,000
-470,200
-5% -$15.8M 0.15% 163
2017
Q1 		$251M Sell
8,632,200
-6,492,200
-43% -$181M 0.14% 174
2016
Q4 		$364M Buy
15,124,400
+10,262,612
+211% +$280M 0.2% 121
2016
Q3 		$151M Buy
4,861,788
+87,188
+2% +$2.75M 0.09% 238
2016
Q2 		$140M Sell
4,774,600
-1,041,000
-18% -$31.2M 0.09% 238
2016
Q1 		$179M Buy
5,815,600
+3,717,400
+177% +$95.9M 0.12% 183
2015
Q4 		$56.3M Sell
2,098,200
-707,000
-25% -$19.6M 0.04% 474
2015
Q3 		$76.4M Sell
2,805,200
-3,268,800
-54% -$89.6M 0.05% 344
2015
Q2 		$167M Sell
6,074,000
-16,835,884
-73% -$408M 0.11% 208
2015
Q1 		$490M Buy
22,909,884
+6,311,500
+38% +$108M 0.34% 50
2014
Q4 		$313M Buy
+16,598,384
New +$355M 0.22% 98

Other funds holding HLF

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
ROIC
Route One Investment Company San Francisco, California $2.35B AUM 11.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

UBS Group's HLF Position: Q1 2026 in Review

UBS Group increased its Herbalife (HLF) stake by 20% in Q1 2026, buying an estimated $481K and bringing the position to 178,352 shares worth $2.63M. The position accounts for ﹤0.01% of the portfolio, ranked #4718.

UBS Group first reported a position in HLF in Q4 2014 and has held it in 46 quarters since. The position peaked at $143M in Q3 2017. 252 funds tracked by Wall St. Rank hold HLF as of Q1 2026.

  • UBS Group held 178,352 shares of Herbalife worth $2.63M as of Q1 2026.
  • UBS Group bought 29,469 Herbalife shares in Q1 2026, an estimated $481K.
  • Herbalife made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #4718 holding.
  • UBS Group first reported a position in Herbalife in Q4 2014 and has held it in 46 quarters since.
  • UBS Group's Herbalife position peaked at $143M in Q3 2017.
  • 252 funds tracked by Wall St. Rank held Herbalife as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.